Intervention Review

Rizatriptan for acute migraine

  1. Anna Oldman1,
  2. Lesley A Smith2,
  3. Henry J McQuay1,
  4. R Andrew Moore1,
  5. Sheena Derry1

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 2 SEP 2001

DOI: 10.1002/14651858.CD003221.pub2

Database Title

Additional Information

How to Cite

Oldman A, Smith LA, McQuay HJ, Moore RA, Derry S. Rizatriptan for acute migraine. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD003221. DOI: 10.1002/14651858.CD003221.pub2.

Author Information

  1. 1

    University of Oxford, Pain Research and Nuffield Department of Anaesthetics, Oxford, Oxfordshire, UK

  2. 2

    Oxford Brookes University, School of Health and Social Care, Oxford, UK

*Maura Moore, Pain Research and Nuffield Department of Anaesthetics, University of Oxford, West Wing (Level 6), John Radcliffe Hospital, Oxford, Oxfordshire, OX3 9DU, UK. maura.moore@pru.ox.ac.uk.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 24 JAN 2007

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (57K)

  1. Current Version

    Rizatriptan for acute migraine

    Anna Oldman, Lesley A Smith, Henry J McQuay, R Andrew Moore and Sheena Derry

    Article first published online: 24 JAN 2007 | DOI: 10.1002/14651858.CD003221.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Rizatriptan for acute migraine

    AD Oldman, LA Smith, HJ McQuay and RA Moore

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD003221

View Full Article (HTML) Full (57K)